NIH funds research on radiation and chemical injuries, injury models, diagnostics, and medical countermeasures for radiological, nuclear, or chemical emergencies; clinical trials are not allowed.
This grant has transitioned from forecasted to posted and is now accepting applications.
NIH supports basic research on how toxic chemicals injure skin to spur discovery and early development of broad-spectrum medical countermeasures; clinical trials are not allowed.
Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.
Grant supports research on skin injuries caused by chemical threats, aiming to identify commonalities for medical countermeasure development.
Funding opportunity for advancing nanotechnology-based cancer treatments to improve effectiveness through innovative nanoparticle designs and cargos.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.